Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -447,779 | -97,933 | -223,170 | -147,275 | -41,721 |
| Other Working Capital | -147,926 | 0 | -89,268 | -200,363 | -63,354 |
| Other Operating Activity | 1,504,258 | 977,674 | 1,059,644 | 1,135,391 | 690,710 |
| Operating Cash Flow | $908,553 | $879,741 | $747,206 | $787,752 | $585,636 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,723,661 | -725,371 | -720,756 | -623,352 | -418,753 |
| Net Acquisitions | 1,977,029 | -595,900 | -324,010 | 250,026 | -193,152 |
| Purchase Of Investment | -5,997 | -18,259 | -11,572 | -13,700 | -13,907 |
| Other Investing Activity | -253,874 | 433,231 | 482,708 | -160,975 | -23,178 |
| Investing Cash Flow | $-1,006,503 | $-906,299 | $-573,630 | $-548,002 | $-648,989 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 38,980 | N/A | N/A | 1,713 | 91,168 |
| Debt Repayment | -53,973 | -162,669 | -64,471 | -61,650 | -20,088 |
| Common Stock Issued | 21,989 | 11,619 | 24,797 | 5,138 | 9,271 |
| Common Stock Repurchased | -182,911 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -5,997 | -8,299 | -13,225 | -11,988 | -6,181 |
| Financing Cash Flow | $-181,911 | $-159,349 | $-52,900 | $-66,788 | $74,170 |
| Beginning Cash Position | 3,187,430 | 522,865 | 775,309 | -126,725 | -177,699 |
| End Cash Position | 2,907,569 | 336,957 | 895,986 | 46,238 | -166,883 |
| Net Cash Flow | $-279,861 | $-185,908 | $120,677 | $172,963 | $10,816 |
| Free Cash Flow | |||||
| Operating Cash Flow | 908,553 | 879,741 | 747,206 | 787,752 | 585,636 |
| Capital Expenditure | -2,751,647 | -844,883 | -755,472 | -638,764 | -431,114 |
| Free Cash Flow | -1,843,094 | 34,858 | -8,266 | 148,988 | 154,521 |